연구성과로 돌아가기
JCR 2024 저널 목록 (295 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| npj Genomic Medicine | NATURE PORTFOLIO | N/A | 2056-7944 | SCIE | GENETICS & HEREDITY | 1,993 | 4.8 | Q1 | 14.9 | 85.1 | 29/191 | 5.0 | Q1 | 4.7 | 0.9 | 1.35 | 22/191 | Q1 | 88.74 | 0.005 | 1.107 | 2.157 | Q1 | 67 | 88.1% | 3.8 | 6.5 | 59 | 99.4% | 2025-08-05 16:03:19 | 바로가기 |
| Photoacoustics | ELSEVIER GMBH | 2213-5979 | 2213-5979 | SCIE | ENGINEERING, BIOMEDICAL | 3,616 | 6.8 | Q1 | 14.9 | 85.1 | 19/124 | 7.3 | Q1 | 5.8 | 1.9 | 2.06 | 9/124 | Q1 | 93.15 | 0.005 | 1.006 | 1.406 | Q1 | 95 | 100.0% | 3.2 | 5.9 | 95 | 93.1% | 2025-08-05 16:03:05 | 바로가기 |
| Seminars in Fetal & Neonatal Medicine | ELSEVIER SCI LTD | 1744-165X | 1878-0946 | SCIE | PEDIATRICS | 3,375 | 2.8 | Q1 | 14.9 | 85.1 | 29/191 | 3.9 | Q1 | 2.8 | 0.2 | 1.32 | 25/191 | Q1 | 87.17 | 0.003 | 0.625 | 1.251 | Q1 | 35 | 97.1% | 8.0 | 7.2 | 34 | 16.3% | 2025-08-05 16:04:31 | 바로가기 |
| Strategic Entrepreneurship Journal | WILEY | 1932-4391 | 1932-443X | SSCI | MANAGEMENT | 3,999 | 6.3 | Q1 | 14.9 | 85.1 | 63/420 | 8.0 | Q1 | 5.9 | 0.7 | 1.15 | 104/421 | Q1 | 75.42 | 0.004 | 0.806 | 3.036 | Q1 | 30 | 100.0% | 7.6 | 11.3 | 30 | 44.4% | 2025-08-05 16:03:51 | 바로가기 |
| ULTRASONICS | ELSEVIER | 0041-624X | 1874-9968 | SCIE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 11,584 | 4.1 | Q1 | 14.9 | 85.1 | 32/212 | 4.2 | Q1 | 3.4 | 1.2 | 1.31 | 27/212 | Q1 | 87.50 | 0.006 | 1.416 | 0.741 | Q2 | 267 | 98.9% | 7.5 | 7.1 | 264 | 15.7% | 2025-08-05 16:05:02 | 바로가기 |
| WATER RESOURCES MANAGEMENT | SPRINGER | 0920-4741 | 1573-1650 | SCIE | WATER RESOURCES | 15,641 | 4.7 | Q1 | 14.9 | 85.1 | 20/131 | 4.2 | Q1 | 4.0 | 1.7 | 1.04 | 22/131 | Q1 | 83.59 | 0.008 | 1.771 | 0.648 | Q2 | 356 | 91.8% | 6.8 | 5.6 | 327 | 16.0% | 2025-08-05 16:05:33 | 바로가기 |
| Antimicrobial Resistance and Infection Control | BMC | 2047-2994 | 2047-2994 | SCIE | INFECTIOUS DISEASES | 6,875 | 4.4 | Q1 | 15.0 | 85.0 | 21/137 | 5.5 | Q1 | 4.1 | 0.7 | 1.14 | 22/137 | Q1 | 84.31 | 0.009 | 1.975 | 1.339 | Q1 | 146 | 89.7% | 5.1 | 5.9 | 131 | 99.3% | 2025-08-05 16:03:36 | 바로가기 |
| BIOCONTROL | SPRINGER | 1386-6141 | 1573-8248 | SCIE | ENTOMOLOGY | 3,200 | 2.7 | Q1 | 15.0 | 85.0 | 17/110 | 2.3 | Q2 | 2.5 | 0.9 | 1.14 | 19/110 | Q1 | 83.18 | 0.001 | 0.266 | 0.483 | Q2 | 63 | 87.3% | 10.1 | 10.0 | 55 | 33.5% | 2025-08-05 16:02:33 | 바로가기 |
| Cardiovascular Intervention and Therapeutics | SPRINGER JAPAN KK | 1868-4300 | 1868-4297 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 1,085 | 5.8 | Q1 | 15.0 | 85.0 | 35/230 | 3.2 | Q2 | 5.3 | 0.4 | 1.02 | 54/230 | Q1 | 76.74 | 0.002 | 0.452 | 0.959 | Q2 | 84 | 86.9% | 3.5 | 6.2 | 73 | 25.0% | 2025-08-05 16:02:37 | 바로가기 |
| Cell Communication and Signaling | BMC | N/A | 1478-811X | SCIE | CELL BIOLOGY | 13,195 | 8.9 | Q1 | 15.0 | 85.0 | 31/204 | 9.1 | Q1 | 8.7 | 2.1 | 1.06 | 55/204 | Q2 | 73.28 | 0.016 | 3.590 | 2.031 | Q1 | 594 | 70.0% | 3.4 | 6.6 | 416 | 99.9% | 2025-08-05 16:02:38 | 바로가기 |
| Current HIV/AIDS Reports | SPRINGER | 1548-3568 | 1548-3576 | SCIE | INFECTIOUS DISEASES | 2,523 | 4.4 | Q1 | 15.0 | 85.0 | 21/137 | 5.4 | Q1 | 4.3 | 0.3 | 0.95 | 33/137 | Q1 | 76.28 | 0.004 | 0.931 | 2.052 | Q1 | 22 | 0.0% | 5.6 | 5.9 | 0 | 36.3% | 2025-08-05 16:03:36 | 바로가기 |
| Current Research in Insect Science | ELSEVIER | N/A | 2666-5158 | ESCI | ENTOMOLOGY | 187 | 2.7 | Q1 | 15.0 | 85.0 | 17/110 | 2.9 | Q1 | 2.6 | 0.4 | 1.20 | 14/110 | Q1 | 87.73 | 0.000 | 0.080 | 0.745 | Q1 | 30 | 100.0% | 2.6 | 11.4 | 30 | 100.0% | 2025-08-05 16:02:33 | 바로가기 |
| DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY | ELSEVIER SCI LTD | 0145-305X | 1879-0089 | SCIE | VETERINARY SCIENCES | 10,115 | 2.4 | Q1 | 15.0 | 85.0 | 26/170 | 2.7 | Q1 | 2.3 | 0.4 | 1.08 | 26/170 | Q1 | 85.00 | 0.005 | 1.079 | 0.515 | Q1 | 146 | 99.3% | 8.6 | 9.4 | 145 | 11.2% | 2025-08-05 16:05:31 | 바로가기 |
| EARTHQUAKE ENGINEERING & STRUCTURAL DYNAMICS | WILEY | 0098-8847 | 1096-9845 | SCIE | ENGINEERING, CIVIL | 17,695 | 5.0 | Q1 | 15.0 | 85.0 | 28/183 | 5.0 | Q1 | 4.4 | 1.1 | 1.12 | 24/184 | Q1 | 87.23 | 0.007 | 1.488 | 0.998 | Q1 | 214 | 100.0% | 11.9 | 9.3 | 214 | 31.3% | 2025-08-05 16:03:06 | 바로가기 |
| Electronic Commerce Research and Applications | ELSEVIER | 1567-4223 | 1873-7846 | SSCI | BUSINESS | 5,933 | 6.3 | Q1 | 15.0 | 85.0 | 48/316 | 7.0 | Q1 | 5.8 | 1.1 | 1.33 | 50/317 | Q1 | 84.38 | 0.004 | 0.930 | 1.176 | Q2 | 100 | 99.0% | 5.6 | 6.5 | 99 | 9.4% | 2025-08-05 16:02:35 | 바로가기 |
페이지 이동: